臺灣健保癌症用藥事前審查實作指引
1.0.4 - release

This page is part of the 臺灣癌症用藥事前審查實作指引(TWPAS IG) (v1.0.4: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Example ClaimResponse: 事前審查回覆

狀態：Active

類型：Institutional

用途：Preauthorization

病人：Patient/pat-min

核定日期：2024-07-30

關聯的事前審查：Claim/cla-1

保險商：Organization 衛生福利部中央健康保險署

處置狀態：Processing Complete

案件受理狀態：審畢結果

item

itemSequence：1

受理審查案件核定註記

-類型受理審查案件核定註記核定數量
*Submitted Amount同意備查 ( NHI-健保事前審查-核定註記#1) )2

個別醫令核定註記

-類型Claim.item.sequence個別醫令核定註記
*Submitted Amount1同意備查 ( NHI-健保事前審查-核定註記#1) )
*Submitted Amount2同意備查 ( NHI-健保事前審查-核定註記#1) )